Inhibition of breast cancer with transdermal tamoxifen-encapsulated lipoplex

BACKGROUND: Tamoxifen is currently used for the treatment of both early and advanced estrogen receptor (ER) positive breast cancer in pre- and post-menopausal women. However, using tamoxifen routinely to inhibit endogenous or exogenous estrogen effects is occasionally difficult because of its potent...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Nanobiotechnology
Autori principali: Lin, Yu-Ling, Chen, Chia-Hung, Wu, Hsin-Yi, Tsai, Nu-Man, Jian, Ting-Yan, Chang, Yuan-Ching, Lin, Chi-Hsin, Wu, Chih-Hsiung, Hsu, Fei-Ting, Leung, Ting Kai, Liao, Kuang-Wen
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2016
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4759757/
https://ncbi.nlm.nih.gov/pubmed/26892504
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12951-016-0163-3
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi